These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 16951384)

  • 1. Antibody targeting to a class I MHC-peptide epitope promotes tumor cell death.
    Wittman VP; Woodburn D; Nguyen T; Neethling FA; Wright S; Weidanz JA
    J Immunol; 2006 Sep; 177(6):4187-95. PubMed ID: 16951384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TCR mimic monoclonal antibody targets a specific peptide/HLA class I complex and significantly impedes tumor growth in vivo using breast cancer models.
    Verma B; Neethling FA; Caseltine S; Fabrizio G; Largo S; Duty JA; Tabaczewski P; Weidanz JA
    J Immunol; 2010 Feb; 184(4):2156-65. PubMed ID: 20065111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TCR mimic monoclonal antibodies induce apoptosis of tumor cells via immune effector-independent mechanisms.
    Verma B; Jain R; Caseltine S; Rennels A; Bhattacharya R; Markiewski MM; Rawat A; Neethling F; Bickel U; Weidanz JA
    J Immunol; 2011 Mar; 186(5):3265-76. PubMed ID: 21282517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing vaccine potency using TCRmimic antibodies.
    Neethling FA; Ramakrishna V; Keler T; Buchli R; Woodburn T; Weidanz JA
    Vaccine; 2008 Jun; 26(25):3092-102. PubMed ID: 18353510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct discovery and validation of a peptide/MHC epitope expressed in primary human breast cancer cells using a TCRm monoclonal antibody with profound antitumor properties.
    Verma B; Hawkins OE; Neethling FA; Caseltine SL; Largo SR; Hildebrand WH; Weidanz JA
    Cancer Immunol Immunother; 2010 Apr; 59(4):563-73. PubMed ID: 19779714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recruitment of CTL activity by tumor-specific antibody-mediated targeting of single-chain class I MHC-peptide complexes.
    Lev A; Novak H; Segal D; Reiter Y
    J Immunol; 2002 Sep; 169(6):2988-96. PubMed ID: 12218113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct phenotypic analysis of human MHC class I antigen presentation: visualization, quantitation, and in situ detection of human viral epitopes using peptide-specific, MHC-restricted human recombinant antibodies.
    Cohen CJ; Sarig O; Yamano Y; Tomaru U; Jacobson S; Reiter Y
    J Immunol; 2003 Apr; 170(8):4349-61. PubMed ID: 12682272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective targeting of melanoma and APCs using a recombinant antibody with TCR-like specificity directed toward a melanoma differentiation antigen.
    Denkberg G; Lev A; Eisenbach L; Benhar I; Reiter Y
    J Immunol; 2003 Sep; 171(5):2197-207. PubMed ID: 12928363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting TARP, a novel breast and prostate tumor-associated antigen, with T cell receptor-like human recombinant antibodies.
    Epel M; Carmi I; Soueid-Baumgarten S; Oh S; Bera T; Pastan I; Berzofsky J; Reiter Y
    Eur J Immunol; 2008 Jun; 38(6):1706-20. PubMed ID: 18446790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opportunities and challenges for TCR mimic antibodies in cancer therapy.
    Chang AY; Gejman RS; Brea EJ; Oh CY; Mathias MD; Pankov D; Casey E; Dao T; Scheinberg DA
    Expert Opin Biol Ther; 2016 Aug; 16(8):979-87. PubMed ID: 27094818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levels of specific peptide-HLA class I complex predicts tumor cell susceptibility to CTL killing.
    Weidanz JA; Nguyen T; Woodburn T; Neethling FA; Chiriva-Internati M; Hildebrand WH; Lustgarten J
    J Immunol; 2006 Oct; 177(8):5088-97. PubMed ID: 17015692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive mutagenesis identifies the peptide repertoire of a p53 T-cell receptor mimic antibody that displays no toxicity in mice transgenic for human HLA-A*0201.
    Trenevska I; Anderson AP; Bentley C; Hassanali T; Wiblin S; Maguire S; Pezzella F; Banham AH; Li D
    PLoS One; 2021; 16(4):e0249967. PubMed ID: 33836029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MHC allele-specific molecular features determine peptide/HLA-A2 conformations that are recognized by HLA-A2-restricted T cell receptors.
    Wang Z; Turner R; Baker BM; Biddison WE
    J Immunol; 2002 Sep; 169(6):3146-54. PubMed ID: 12218132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct detection and quantitation of a distinct T-cell epitope derived from tumor-specific epithelial cell-associated mucin using human recombinant antibodies endowed with the antigen-specific, major histocompatibility complex-restricted specificity of T cells.
    Cohen CJ; Hoffmann N; Farago M; Hoogenboom HR; Eisenbach L; Reiter Y
    Cancer Res; 2002 Oct; 62(20):5835-44. PubMed ID: 12384546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation and characterization of human recombinant antibodies endowed with the antigen-specific, major histocompatibility complex-restricted specificity of T cells directed toward the widely expressed tumor T-cell epitopes of the telomerase catalytic subunit.
    Lev A; Denkberg G; Cohen CJ; Tzukerman M; Skorecki KL; Chames P; Hoogenboom HR; Reiter Y
    Cancer Res; 2002 Jun; 62(11):3184-94. PubMed ID: 12036932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TCR-like antibodies mediate complement and antibody-dependent cellular cytotoxicity against Epstein-Barr virus-transformed B lymphoblastoid cells expressing different HLA-A*02 microvariants.
    Lai J; Choo JAL; Tan WJ; Too CT; Oo MZ; Suter MA; Mustafa FB; Srinivasan N; Chan CEZ; Lim AGX; Zhong Y; Chan SH; Hanson BJ; Gascoigne NRJ; MacAry PA
    Sci Rep; 2017 Aug; 7(1):9923. PubMed ID: 28855662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tax and M1 peptide/HLA-A2-specific Fabs and T cell receptors recognize nonidentical structural features on peptide/HLA-A2 complexes.
    Biddison WE; Turner RV; Gagnon SJ; Lev A; Cohen CJ; Reiter Y
    J Immunol; 2003 Sep; 171(6):3064-74. PubMed ID: 12960332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunodominant West Nile Virus T Cell Epitopes Are Fewer in Number and Fashionably Late.
    Kaabinejadian S; McMurtrey CP; Kim S; Jain R; Bardet W; Schafer FB; Davenport JL; Martin AD; Diamond MS; Weidanz JA; Hansen TH; Hildebrand WH
    J Immunol; 2016 May; 196(10):4263-73. PubMed ID: 27183642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a T-cell receptor mimic antibody targeting a novel Wilms tumor 1-derived peptide and analysis of its specificity.
    Kurosawa N; Midorikawa A; Ida K; Fudaba YW; Isobe M
    Cancer Sci; 2020 Oct; 111(10):3516-3526. PubMed ID: 32770595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and implementation of a direct detection, quantitation and validation system for class I MHC self-peptide epitopes.
    Weidanz JA; Piazza P; Hickman-Miller H; Woodburn D; Nguyen T; Wahl A; Neethling F; Chiriva-Internati M; Rinaldo CR; Hildebrand WH
    J Immunol Methods; 2007 Jan; 318(1-2):47-58. PubMed ID: 17134715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.